FDA Drug Shortages: Methylphenidate Hydrochloride Extended-Release Tablets, USP CII

Methylphenidate Hydrochloride Extended-Release Tablets, USP CII
Status: Discontinuation
»Therapeutic Categories: Pediatric; Psychiatry
 

 

Presentation Posting Date Related Information
36 mg 30 count (NDC 0591-2717-30) 05/17/2019 Teva made a business related decision to discontinue the product.
54 mg 30 count (NDC 0591-2718-30) 05/17/2019 Teva made a business related decision to discontinue the product.

To read more Press Release articles, click here.